Search research articles
Contact Us
Filters
Showing results (191-200 of 243) with videos related to
Page
of 25
Sort By:
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
Timothy P DiPeri, Mehmet Demirhan, Daniel D Karp, et al.
Journal for Immunotherapy of Cancer
|
April 18, 2019
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
Noha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, et al.
JCO Clinical Cancer Informatics
|
March 21, 2019
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy
Jessica P Hwang, Danmeng Huang, John M Vierling, et al.
Seminars in Arthritis and Rheumatism
|
October 23, 2016
Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials
Simon Tarp, Daniel E Furst, Anna Dossing, et al.
JMIR Cancer
|
October 25, 2024
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study
Maria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, et al.
Seminars in Arthritis and Rheumatism
|
June 2, 2022
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group
José B Negrón, Maria A Lopez-Olivo, Loreto Carmona, et al.
Arthritis and Rheumatism
|
June 2, 2006
Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus
Javier P Berrios-Rivera, Richard L Street, Maria G Garcia Popa-Lisseanu, et al.
Journal for Immunotherapy of Cancer
|
November 23, 2019
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
Houssein Safa, Daniel H Johnson, Van Anh Trinh, et al.
Cancers
|
August 12, 2023
Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors
Maria A Lopez-Olivo, Johncy J Kachira, Maryam Buni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
Maria E Suarez-Almazor, Xerxes Pundole, Noha Abdel-Wahab, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 243) with videos related to
Sort By:
Page
of 25
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
Timothy P DiPeri, Mehmet Demirhan, Daniel D Karp, et al.
Journal for Immunotherapy of Cancer
|
April 18, 2019
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
Noha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, et al.
JCO Clinical Cancer Informatics
|
March 21, 2019
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy
Jessica P Hwang, Danmeng Huang, John M Vierling, et al.
Seminars in Arthritis and Rheumatism
|
October 23, 2016
Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials
Simon Tarp, Daniel E Furst, Anna Dossing, et al.
JMIR Cancer
|
October 25, 2024
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study
Maria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, et al.
Seminars in Arthritis and Rheumatism
|
June 2, 2022
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group
José B Negrón, Maria A Lopez-Olivo, Loreto Carmona, et al.
Arthritis and Rheumatism
|
June 2, 2006
Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus
Javier P Berrios-Rivera, Richard L Street, Maria G Garcia Popa-Lisseanu, et al.
Journal for Immunotherapy of Cancer
|
November 23, 2019
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
Houssein Safa, Daniel H Johnson, Van Anh Trinh, et al.
Cancers
|
August 12, 2023
Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors
Maria A Lopez-Olivo, Johncy J Kachira, Maryam Buni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
Maria E Suarez-Almazor, Xerxes Pundole, Noha Abdel-Wahab, et al.
Page
of 25